Commensal microbes and sexual dimorphism in autoimmunity
Commensal microbes and sexual dimorphism in autoimmunity
批准号:
8828075
负责人:
ALEXANDER V CHERVONSKY
金额:
$23.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2017-03-31
关键词:
AccountingAddressAdultAffectAnimal ModelAntibiotic TherapyAutoimmune DiseasesAutoimmunityChicagoComplexDataDependenceDevelopmentDiabetes MellitusDiseaseDisease ProgressionEnvironmentFemaleGenderGene ExpressionGene Expression ProfilingGenetic VariationGerm-FreeGnotobioticGonadal Steroid HormonesHealthHormonalHormonesHumanImmunityInbred NOD MiceIncidenceInsulin-Dependent Diabetes MellitusInterferon Type IIKnowledgeLeadMetabolismMicrobeMinorModelingMultiple SclerosisMusMutationProceduresProductionPublicationsPublishingRegulationReportingResearchResistanceRoleSclerodermaSignal PathwaySignal TransductionSjogren&aposs SyndromeSterilitySurveysSystemSystemic Lupus ErythematosusT-LymphocyteTestingTestosteroneThe Jackson LaboratoryThyroid GlandTimeUncertaintyUniversitiesWorkantimicrobialcell typecommensal microbesgenetic approachmacrophagemalemicrobialmouse modelrepositorysexual dimorphism
中文摘要
描述(由申请人提供):许多主要的自身免疫性疾病是两性二态的。系统性红斑狼疮(SLE)、硬皮病、多发性硬化症、干燥综合征、甲状腺自身免疫性疾病等主要发生在女性身上。在自发性1型糖尿病小鼠模型中(非肥胖糖尿病小鼠中的T1D),这种疾病在雌性中更强。一项对世界各地NOD群体的调查发现,不仅T1D的总体发病率在不同的设施之间差异很大,而且女性/男性发病率也有所不同。这种可变性表明,一些不容易解释的因素明显影响了疾病的进展。在其他设施中,包括我们的,雄性的发病率甚至更低(30周时约为15-20%),而雌性的发病率约为65-80%。作为微生物环境对T1D发育作用研究的一部分,我们将NOD小鼠重新导出到无菌(无菌)条件下。我们意识到这些老鼠不再表现出性别二态性!这意味着激素(清楚地表明是相关的)和微生物群以某种方式相互作用,影响疾病的进展。我们的主要假设认为激素和微生物产物共同作用(双信号假设)诱导雄性对T1D的耐受性。初步分析揭示了干扰素- γ在保护男性T1D中的作用。建议通过多种方法来验证这一假设,包括确定微生物群的无菌小鼠定殖,遗传方法和基因表达分析。我们还将测试在一个常见的遗传复杂的SLE小鼠模型中,由于微生物的存在,系统免疫是否也存在性别二态性。因此,有两个具体目标:研究使NOD雄性对T1D更具抗性的效应机制。我们将测试特定微生物谱系在控制两性异形中的作用;我们将利用基因表达和遗传方法研究参与耐受性诱导的信号通路和细胞类型。我们将研究如何操纵性激素影响微生物组成和功能;我们将使用基因表达分析来描述对微生物群的激素依赖性控制重要的信号通路。具体目标3。研究SLE小鼠模型中的两性异形是否依赖于微生物。我们将在无菌环境下研究微生物群在诱导NZBWF1小鼠雌雄二态性中的作用。
英文摘要
DESCRIPTION (provided by applicant): Many of major autoimmune diseases are sexually dimorphic. Systemic Lupus Erythematosus (SLE), scleroderma, multiple sclerosis, Sjogren's syndrome, autoimmune diseases of thyroid gland and others are primarily occurring in females. In a mouse model of spontaneous type 1 diabetes (T1D in non-obese diabetic, NOD, mice) the disease is stronger in females. A survey of NOD colonies around the world found that not only overall incidence of T1D varied greatly between different facilities, but that the female/male incidence ratio varied. The variability suggests that some factors that cannot be easily accounted for clearly affect the disease progression. In other facilities, including ours, the incidence in males is even lower (about 15-20% at 30 wks), whereas the incidence in females is around 65-80%. As a part of the studies of the role of microbial environment on T1D development, we have rederived NOD mice into germ-free (sterile) conditions. We realized that these mice no longer showed sexual dimorphism! That means that the hormones (clearly shown to be involved) and the microbiota are interacting in some way that affects the disease progression. Our main hypothesis suggests that the hormones and microbial products act together (dual-signal hypothesis) to induce tolerance to T1D in males. Preliminary analysis has revealed a role for Interferon-gamma in protection of males from T1D. It is proposed to test the hypothesis by a variety of approaches including colonization of germ-free mice with defined microbiota, genetic approach and gene expression analysis. We will also to test whether systemic immunity in a common genetically complex mouse model of SLE is also sexually dimorphic because of the presence of microbes. Accordingly, two specific aims are: Specific Aim 1. Investigate the effector mechanisms that make NOD males more resistant to T1D. We will test the role of specific microbial lineages in controlling sexual dimorphism; we will study te signaling pathway and cell types involved in tolerance induction using gene-expression and genetic approaches. We will study how manipulations of sex hormones affect microbial composition and functions; we will use gene expression analysis to delineate signaling pathways important for hormone-dependent control over microbiota. Specific Aim 3. Investigate whether sexual dimorphism in a mouse model of SLE is dependent on microbes. We will study the role of microbiota in induction and sexual dimorphism in NZBWF1 mice in germ-free environment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancement of autoimmunity in type 1 diabetes by gluten
-
批准号:10390844
-
项目类别:
-
资助金额:$61.81万
-
财政年份:2021
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Enhancement of autoimmunity in type 1 diabetes by gluten
-
批准号:10490911
-
项目类别:
-
资助金额:$58.03万
-
财政年份:2021
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Enhancement of autoimmunity in type 1 diabetes by gluten
-
批准号:10680525
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2021
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
-
批准号:9388410
-
项目类别:
-
资助金额:$55.2万
-
财政年份:2017
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
-
批准号:10216963
-
项目类别:
-
资助金额:$54.6万
-
财政年份:2017
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Host's and microbiota's contribution to sexual dimorphism of autoimmunity
-
批准号:10608647
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2017
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Diet and microbiota in type 1 diabetes
-
批准号:8815476
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2014
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Commensal microbes and sexual dimorphism in autoimmunity
-
批准号:8643918
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2014
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Intravital Imaging of Type I Diabetes
-
批准号:8114678
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2011
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Intravital Imaging of Type I Diabetes
-
批准号:8690037
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2011
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Intravital Imaging of Type I Diabetes
-
批准号:8502482
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2011
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Intravital Imaging of Type I Diabetes
-
批准号:8887109
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2011
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Intravital Imaging of Type I Diabetes
-
批准号:8294706
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2011
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Type 1 diabetes: the role of commensal microbiota
-
批准号:8261134
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2010
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Type 1 diabetes: the role of commensal microbiota
-
批准号:8640874
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2010
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Type 1 diabetes: the role of commensal microbiota
-
批准号:9297198
-
项目类别:
-
资助金额:$48.47万
-
财政年份:2010
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Type 1 diabetes: the role of commensal microbiota
-
批准号:7986961
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2010
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Type 1 diabetes: the role of commensal microbiota
-
批准号:8452045
-
项目类别:
-
资助金额:$35.77万
-
财政年份:2010
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Type 1 diabetes: the role of commensal microbiota
-
批准号:8072706
-
项目类别:
-
资助金额:$38.61万
-
财政年份:2010
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
Fas in host defense and autoimmune diseases
-
批准号:7334724
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2007
-
负责人:ALEXANDER V CHERVONSKY
-
依托单位:
海外基金